L. Bergougnoux

发表

Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period

P. Delmas, P. Garnero, ML Nguyên-Pascal, 2005, Climacteric : the journal of the International Menopause Society.

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

X. Pivot, F. Bidard, J. Pierga, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Capecitabine plus oxaliplatin (XELOX) versus 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) as first‐line treatment for metastatic colorectal cancer

T. Conroy, M. Ychou, M. Ducreux, 2011, International journal of cancer.

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.

G. Salles, A. Fischer, É. Oksenhendler, 2006, Blood.

EFFICACY AND SAFETY OF RITUXIMAB IN B-CELL POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: RESULTS OF A PROSPECTIVE MULTICENTRE PHASE II STUDY Running head: Rituximab in PTLD

G. Salles, A. Fischer, É. Oksenhendler, 2017 .

Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up.

G. Salles, H. Tilly, N. Brousse, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Epoetin β Once-Weekly Therapy in Anemic Patients with Solid Tumors and Non-Myeloid Hematological Malignancies Receiving Chemotherapy

S. Oudard, N. Ifrah, K. Ghomari, 2008, Oncology.

Single Treatment with Rituximab Monotherapy for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with Extended Follow-Up (F/Up) of 7 Years.

G. Salles, H. Tilly, N. Brousse, 2006 .

CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.

O. Toupance, J. Goujon, Y. Le Meur, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Detection of BRAF V600 Mutations in Melanoma: Evaluation of Concordance between the Cobas® 4800 BRAF V600 Mutation Test and the Methods Used in French National Cancer Institute (INCa) Platforms in a Real-Life Setting

J. Solassol, J. Scoazec, J. Merlin, 2015, PloS one.

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group

P. Laurent-Puig, J. Sabourin, J. Emile, 2013, BMC Cancer.

A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.

J. Rossi, G. Salles, G. Delsol, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Incidence, Risk Factors and Clinical Consequences of Neutropenia Following Kidney Transplantation: A Retrospective Study

E. Thervet, C. Legendre, M. Mamzer, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study

A. Vincent-Salomon, T. Delozier, M. Namer, 2010, The oncologist.

Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up.

G. Salles, H. Tilly, N. Brousse, 2012 .

Epoetin beta treatment of chemotherapy induced anemia in cancer patients: Results of a large prospective cohort study

S. Mathoulin-Pélissier, I. Ray-Coquard, C. Haioun, 2007 .